cbdMD Inc. (YCBD): Price and Financial Metrics


cbdMD Inc. (YCBD): $0.72

0.00 (0.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

YCBD POWR Grades


  • YCBD scores best on the Sentiment dimension, with a Sentiment rank ahead of 38.97% of US stocks.
  • The strongest trend for YCBD is in Growth, which has been heading down over the past 161 days.
  • YCBD ranks lowest in Growth; there it ranks in the 6th percentile.

YCBD Stock Summary

  • YCBD has a market capitalization of $63,026,178 -- more than approximately only 10.96% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, cbdMD Inc is reporting a growth rate of 376.77%; that's higher than 94.28% of US stocks.
  • In terms of volatility of its share price, YCBD is more volatile than 92.94% of stocks we're observing.
  • Stocks that are quantitatively similar to YCBD, based on their financial statements, market capitalization, and price volatility, are BSVN, SUNW, COLB, NTB, and MYFW.
  • Visit YCBD's SEC page to see the company's official filings. To visit the company's web site, go to www.cbdmd.com.

YCBD Valuation Summary

  • YCBD's price/sales ratio is 2.7; this is 28.95% lower than that of the median Healthcare stock.
  • Over the past 45 months, YCBD's price/sales ratio has gone down 4.6.
  • Over the past 45 months, YCBD's EV/EBIT ratio has gone up 22.3.

Below are key valuation metrics over time for YCBD.

Stock Date P/S P/B P/E EV/EBIT
YCBD 2021-08-31 2.7 1.4 -4.4 -4.2
YCBD 2021-08-30 2.7 1.4 -4.4 -4.2
YCBD 2021-08-27 2.6 1.4 -4.3 -4.1
YCBD 2021-08-26 2.7 1.4 -4.4 -4.2
YCBD 2021-08-25 2.6 1.3 -4.3 -4.1
YCBD 2021-08-24 2.5 1.3 -4.2 -3.9

YCBD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • YCBD has a Quality Grade of D, ranking ahead of 8.65% of graded US stocks.
  • YCBD's asset turnover comes in at 0.394 -- ranking 43rd of 50 Consumer Goods stocks.
  • 500 - Internal server error

The table below shows YCBD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.394 0.660 -1.263
2021-03-31 0.398 0.652 -1.673
2020-12-31 0.384 0.654 -0.407
2020-09-30 0.384 0.630 0.483
2020-06-30 0.370 0.647 1.350
2020-03-31 0.354 0.643 0.476

YCBD Stock Price Chart Interactive Chart >

Price chart for YCBD

YCBD Price/Volume Stats

Current price $0.72 52-week high $3.47
Prev. close $0.71 52-week low $0.56
Day low $0.71 Volume 136,200
Day high $0.79 Avg. volume 282,085
50-day MA $0.80 Dividend yield N/A
200-day MA $1.32 Market Cap 42.44M

cbdMD Inc. (YCBD) Company Bio


cbdMD, Inc. is a nationally recognized consumer cannabidiol brand which engages in producing and distributing of CBD products. Its products include CBD tinctures, CBD gummies, CBD topical, CBD bath bombs, and CBD pet products. cbdMD was founded by Caryn Dunayer in March 2015 and is headquartered in Charlotte, NC.


YCBD Latest News Stream


Event/Time News Detail
Loading, please wait...

YCBD Latest Social Stream


Loading social stream, please wait...

View Full YCBD Social Stream

Latest YCBD News From Around the Web

Below are the latest news stories about cbdMD Inc that investors may wish to consider to help them evaluate YCBD as an investment opportunity.

cbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD’s Extensive Safety Submission

CHARLOTTE, N.C., February 22, 2022--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the "Company"), one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, today announced that the Natural Products Association (NPA) filed a Citizen’s Petition on cbdMD’s behalf with the Food and Drug Administration (FDA) requesting the FDA to remove the drug exclusion for CBD and to review the Company’s extensive dossier of identity, safety and quality data.

Yahoo | February 22, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Rise and shine, trader!

William White on InvestorPlace | February 17, 2022

cbdMD Becomes First American CBD Brand to Receive Validation by the United Kingdom Food Standards Agency

CHARLOTTE, N.C., February 17, 2022--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the "Company") announced today that it has received validation of its Novel Food application from the United Kingdom’s Food Standards Agency ("FSA") (the "Validation") for its natural plant-based CBD formulation and is now the first American CBD brand to achieve this significant milestone. The Company also anticipates validation of its application to the European Food Safety Authority in the coming weeks.

Yahoo | February 17, 2022

cbdMD Completes Third Full Year Results; Total Brands Sales of $118.7 Million Exceeds Initial Earn Out Target

CHARLOTTE, N.C., February 10, 2022--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation’s leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, -- today we announced our financial results for December 31, 2021, the first quarter of our fiscal year ended September 30, 2022 and the third full year of operations with our cb

Yahoo | February 10, 2022

cbdMD Becomes The First CBD Company With NSF International''s Certified For Sport Certification

Wellness CBD company cbdMD, Inc. (NYSE: YCBD ) announced that it is the first and only CBD company to earn the highly respected designation of NSF Certified for Sport , which opens the door to acceptance by major sports leagues in the USA and internationally. The company''s award-winning, patent-pending proprietary broad spectrum hemp extract blend containing CBD, CBG and CBN passed the rigorous testing standards set forth by NSF International . Four of the company''s flagship products containing this blend were specifically submitted for Certified for Sport certification. The company''s 30-count 1500 mg CBD oil softgels, 60-count 3000 mg CBD oil softgels, 30-count 500 mg PM softgels, and 60-count 1000 mg PM softgels each earned certification from NSF International''s Certified for Spor...

Benzinga | February 7, 2022

Read More 'YCBD' Stories Here

YCBD Price Returns

1-mo 11.77%
3-mo -9.49%
6-mo -51.68%
1-year -76.39%
3-year -88.31%
5-year N/A
YTD -33.33%
2021 -63.39%
2020 30.53%
2019 -26.86%
2018 -28.97%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9016 seconds.